PROMETHEUS BIOSCIENCES INC (RXDX) 108.68 +0.25 (+0.23%)
108.68 +0.25 (+0.23%)
US74349U1088 - Common Stock - After market: 108.68 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 149.11. This target is 37.2% above the current price.
RXDX was analyzed by 17 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about RXDX.
In the previous month the buy percentage consensus was at a similar level.
RXDX was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-01-31 | Goldman Sachs | Maintains | Buy |
| 2022-12-08 | BTIG | Maintains | Buy |
| 2022-12-08 | Oppenheimer | Maintains | Outperform |
| 2022-12-08 | RBC Capital | Maintains | Outperform |
| 2022-12-08 | Credit Suisse | Maintains | Outperform |
| 2022-11-01 | Stifel | Maintains | Buy |
| 2022-10-04 | Oppenheimer | Maintains | Outperform |
| 2022-10-04 | RBC Capital | Maintains | Outperform |
| 2022-10-03 | BTIG | Maintains | Buy |
| 2022-08-29 | Wells Fargo | Maintains | Overweight |
| 2022-08-29 | Piper Sandler | Maintains | Overweight |
| 2022-08-12 | SVB Leerink | Maintains | Outperform |
| 2022-08-12 | Credit Suisse | Maintains | Outperform |
| 2022-07-20 | Goldman Sachs | Initiate | Buy |
| 2022-06-10 | Piper Sandler | Initiate | Overweight |
| 2022-05-13 | RBC Capital | Maintains | Outperform |
| 2022-05-13 | Wells Fargo | Maintains | Overweight |
| 2022-03-10 | SVB Leerink | Maintains | Outperform |
| 2022-03-10 | Wells Fargo | Maintains | Overweight |
| 2022-03-10 | Credit Suisse | Maintains | Outperform |
| 2022-02-11 | BTIG | Initiate | Buy |
| 2021-12-13 | RBC Capital | Initiate | Outperform |
| 2021-12-08 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2021-12-08 | SVB Leerink | Maintains | Outperform |
| 2021-12-08 | Wells Fargo | Initiate | Overweight |
| 2021-11-15 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2021-11-15 | SVB Leerink | Maintains | Outperform |
| 2021-10-05 | Oppenheimer | Initiate | Outperform |
| 2021-04-06 | Guggenheim | Initiate | Buy |
| 2021-04-06 | SVB Leerink | Initiate | Outperform |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA